Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The ideal candidate will have experience working on pipeline molecules in Oncology, strong problem-solving skills, a strategic mindset, and will exhibit curiosity, flexibility, and be comfortable with ambiguity.
Requirements
- Develops and maintains long-term forecast models and scenario plans for RevMed’s products across indications.
- Provides portfolio level views and analyses to support organizational decision making via streamline models and consolidation processes.
- Communicates and aligns key internal stakeholders around key forecast assumptions.
- Synthesizes and communicates the similarities, differences, and considerations necessary to inform Global clinical development plans.
- Exhibits analytical rigor in the valuation of business opportunities and the quantification of risk.
- Participates in cross-functional teams to gather input for functional activities, and ensure alignment.
- Partners closely with other Insights and Analytics functions (Market Research, Data Analytics, Competitive Intelligence) to inform the forecast.
- Works closely with Pipeline Marketing, Clinical Development, Portfolio Management, and Medical Affairs to support early-stage decision making.
- Works closely with Regional forecasting leads to ensure consistency and understand differences in forecasts.
- Maintains an in-depth understanding of Revolution Medicines’ diverse product offerings, competitive positioning, and the broader market dynamics shaping the industry's future.
- Collaborates with vendor partners to manage various deliverables and analyses.
Benefits
- Competitive cash compensation
- Robust equity awards
- Strong benefits
- Significant learning and development opportunities
